Noradrenaline Sintetica 1mgml Concentrate for Solution for Infusion Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

noradrenaline sintetica 1mgml concentrate for solution for infusion

intega sdn. bhd. - noradrenaline tartrate -

BACLOFEN injection United States - English - NLM (National Library of Medicine)

baclofen injection

sintetica s.a. - baclofen (unii: h789n3fke8) (baclofen - unii:h789n3fke8) - baclofen 10 mg in 20 ml

Baclofen Sintetica New Zealand - English - Medsafe (Medicines Safety Authority)

baclofen sintetica

boucher & muir (new zealand) limited t/a bnm group - baclofen 0.5 mg/ml - solution for infusion - 0.5 mg/ml - active: baclofen 0.5 mg/ml excipient: sodium chloride water for injection - intrathecal baclofen is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.

Baclofen Sintetica New Zealand - English - Medsafe (Medicines Safety Authority)

baclofen sintetica

boucher & muir (new zealand) limited t/a bnm group - baclofen 2 mg/ml - solution for infusion - 2 mg/ml - active: baclofen 2 mg/ml excipient: sodium chloride water for injection - intrathecal baclofen is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.

Baclofen Sintetica New Zealand - English - Medsafe (Medicines Safety Authority)

baclofen sintetica

boucher & muir (new zealand) limited t/a bnm group - baclofen 0.05 mg/ml - solution for injection - 0.05 mg/ml - active: baclofen 0.05 mg/ml excipient: sodium chloride water for injection - intrathecal baclofen is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.

Ampres 10mg/ml solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

ampres 10mg/ml solution for injection

sintetica ireland limited - chloroprocaine hydrochloride - solution for injection - 10 milligram(s)/millilitre - esters of aminobenzoic acid; chloroprocaine

Ampres 20 mg/ml solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

ampres 20 mg/ml solution for injection

sintetica ireland limited - chloroprocaine hydrochloride - solution for injection - 20 milligram(s)/millilitre - esters of aminobenzoic acid; chloroprocaine

Sinora 0.08 mg/ml solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

sinora 0.08 mg/ml solution for infusion

sintetica ireland limited - norepinephrine bitartrate - solution for infusion - 0.08 milligram(s)/millilitre - adrenergic and dopaminergic agents; norepinephrine

Sinora 0.16 mg/ml solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

sinora 0.16 mg/ml solution for infusion

sintetica ireland limited - norepinephrine bitartrate - solution for infusion - 0.16 milligram(s)/millilitre - adrenergic and dopaminergic agents; norepinephrine

Sinora 0.1 mg/ml solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

sinora 0.1 mg/ml solution for infusion

sintetica ireland limited - noradrenaline tartrate - solution for infusion - 0.1 milligram(s)/millilitre - adrenergic and dopaminergic agents; norepinephrine